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surgioal repair in the neonatal period. BA is safe and effective in relieving
restenosis with a success rate at intermediate follow-up of 95%, in our series,
with 80% of patients requiring only one such procedure.
1954-1461 SinusNodeDY*functi~nF~ll~~ing~~dified
Fontan Operation (Total Cave-Pulmonary
Connection)
A. Hussain, B.1.Bromberg, C.B. Huddleston. Washington UrriversitySc/roo/
of Medicine, St. Louis, Missouri, USA
Background: The modified Fontan operation, or total cavopulmonary con-
nection has been a commonly employed palliative surgery for children with
single ventricle physiology. Preservation of sinus node function may be es-
pecially important following this operation. We evaluated the short-term and
intermediate-term effects of the modified Fonten operation on sinus rhythm
using 24 hour Helter monitoring.
hfethodsand Resu/t: From January 1992 to April 1995,27 patients under
went the modified Fonfan operation. Their mean age at the time of surgery
was 2.9 +0.75 yeara. Hoiter monitors were obtained the day prior to surgery,
the day prior to hospital discharge, and a minimum of 9 montheafter surge~.
The results were comparad to21 patients undergoing secundum ASD repair,
who aleo had pra-operative and pre-discharga Holters. All patients were in
sinus rhythm prior to surgery. Pre-discharge Helter monitors demonstrated
ainus rhythm in all patients following ASD repair. Of those undergoing mod-
ified Fontan repair 77Y0(20/26) were in a ainus or atriai rhythm and 23Y0
‘(6/26) in junctional rhythm post-operatively (p = 0.01). Intermediate-term
Holters obtained in 22 patients 3.2 + 1.2 years (mean + SD) aftera modified
Fontan repair demonstrated that the incidence of junctional rhythm increased
to41% (p c 0.001). Two patients with junctional rhythm developed signs and
symptoms of mcxferateto severe congestive heart failure 4-8 weeks after the
surgery which resolved by re-establishing atrial ventricular synchrony with
permanent atrial pacing. For patients undergoing a modified Fontan repair
there was a significant decrease in average awake heart rate (98 + 10 vs
115 + 13, p < 0.001) in the intermediate-term pest-operative Helter when
compared to the pre-operative study.This was also true for average sleeping
hearl rate (74+ 13 vs 99 + 11,p < 0.0001), maximum heart rate (142+21
vs 158+ 21, p < 0.04) and minimum HR (57 + 14 vs 71 + 13, p < 0.005).
Conclusion: Sinus node dysfunction is a common complication of the
modified Fontan operation and may worsen with time. It frequently results in
chronotropic incompetence and loss of atrioventricular synchrony.
m954147 “Atriovantricular Groove” Tachycardias in Small
Children: Clinical Charactariatics and Treatment
Stretagiea
C.L. Case, K. Avasarala, P.Gillette. Cook Chi/dren’sArrhytf’rrrriaCentec
Fort Worth, Texas, USA
This study examines the clinical characteristics and management options in
a group of 4 small children (3 f, 1 m; ages 1-21 mos at presentation) who had
both complex atrial and ventricular arrhythmias. The substrate responsible
for these arrhythmias most likely involves tumor(s) which traverse the AV
groove. All 4 pts had WPWon their EKG at presentation. Initial tachycerdias
were orthcdromic SVT (2), antidromic SVT (l), and VT (l). Three out of the
4 patients had catastrophic episodea of VT with cardiac arrest and/or death.
Tumors involving the AV groove were identified by imaging in 2 of 4 pts (MRI
and echo). AV groove substrates were confirmed in the other2 pts by EPdata
obtained at catheter ablation procedures. Three of the 4 pts are alive and
well. One child died suddenly at home from VTon amiodarone and fleceinide
6mosfollowingsuccessful surgery forWpkV. Onept wassucceasfully treated
with intensive drug therapy (combination Class 1,II and Ill drugs) for VT after
the resolution of the WPW syndrome. Twopts were successfully treated with
ostheter ablation. One of these pts had WPW ablated, but PVCSemanating
from the “ventricular end” of the substrate persist. The other pt had WPW
and VT originating from the anterior septal region successfully ablated after
pre.%ntingwith oerdiac arrest and 6 months of ineffective in-hpepital medical
treatment of VT. Conclusion: Small children with WPW may have complex,
lethal atrfal and ventricular arrhythmias secondary to tumors traversing the
AV groove. Aggressive therapies maybe needed to control symptoms and
avoid sudden cardiac death.
1954-1481 Th~:ln~OfVaraPami, on Feti,Cardia~
S.K. Sandhu, J.L. Heckman, R.K. Balsars, P.Russo, J.M. Dunn. St.
Christopher’a Hoepital For Children, Philadelphia, PA, USA
Calcium channel blockers may be utilized during pregnancy as a maternal
or fetal antiarrhythmic or tocolytic agent. Since the t-tubule and sarcoplasmlc
reticulum are not fully developed in the fetal heart, it is likely that the negative
inotropic effect of calcium channel blockers witl be axaggeratad in the fetus.
The effect of verapamil on fetal cardiac contractile mechanics was stud-
ied in 5 fetal hearts (135 days gestation) employing an isolated isovolumetric
contracting preparation. The systolic and diastolic volume-pressure relation-
ship was determined before (control) and after the infusion of subclinical and
clinical levels of verapamil.
Verapamil blood levels obtained were sub to Iowtherapeutic in each case
(67-146 Kg/L). The peak left ventricular developed pressure (LVPDP) and
enddiastolic pressure (LVEDP) at a physiologic 5 mm Hg preloed were sig-
nificantly reduced even when verapamil levels were subclinical. The volume-
pressure curve was shifted downward.
Control(mean+ SEM) VeraDamilHa) (mean+ SEM) D-vslue
(mm Hgj (mm’Hg) “
LVEDP 18.4 + 1.2 9.6 + 1.5 n,s
LVPDP 65.6 + 2,4 19.3 * 2.0 <0.05
We conclude that Verapamil exerts a severe negative inotropic effect on
the fetal heart, far greater than expected from the adult literature. Since we
and others have demonstrated placental transfer of verapemil, its use in the
pregnant female is relatively contraindicated. Also, since the neonatal heart
most likely represents a transition between the fetal and mature myocardium,
its use in the pregnant females and neonates should also be questioned.
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-[ Rigl’ttVentri..lar DyafunCtiOnFObving
Succeaaful Reauacitation From Prolongad
Cardiac Arrest
K.B. Kern, R.W. Hilwig, R.A. Berg, K.H. Rhee, A.B. Sanders, C.W. Offo,
G.A. Ewy. The UrriversityofArizona, Tucson,Arizona, USA
Resuscitation following 10 to 15 minutes of untreated ventricular fibrillation
results in a traumatic decrease in left ventricular systolic and diastolic func-
tion. To evaluate the effect of prolonged cardiac arrest and resuscitation on
right ventricular function 28 swine, 16 control animals and 12 which received
Dobutamine (10 @kg/rein) were studiedfor5 hours post-resuscitation. Each
was instrumented with solid state micromanometer-tipped pigtail catheters
to measure right ventricular end-diastolic pressure and perform right ventric-
ular angiography to calculate right ventricular ejection fraction. A 10 to 15
minute period of ventricular fibrillation ”followed by resuscitation was utilized.
There were significant differences over time in both end-diastolic pressure
and ejection fraction in the control group. Table 1 showa the difference at




Baseline 5+1 4*1 0.88
30 min. 6+1 4*1 0.004
2 hr. 4*1 4*1 0.64
5 hr. 5+1 3*1 0.23
RVEF (“A)
Baesline 50 i 2 50 z! 2 0.97
30 min. 34 i 2 42+ 4 0.13
2 hr. 40 i 2 49 i 2 0.01
5 hr. 41 +2 47& 4 0.14
l%olonged cardiac arrest followed by successful resuscitation results in
significant right ventricular dysfunction. Dobutamine can significantly improve
this post-resuscitation right ventricular dysfunction.
1955-1681 CompariaOnOf~pinephrina andphany,aphrinein
Resuscitation From Cardiac Arrast Uaing
Salectiva Aortic Parfusion and Oxygenation
N.A. Paradis, C.M. Davison, J. Fuller. Department ofkfedicine, Columbia
University College of physicians and Surgeons, and Emergency Medicine,
St. Luke’e#RooseveltHospital, New York, NY USA
Pumose: To comoare eoineohrine fEPl) and ohenvleohrirte (PHE) as intra-...r--–. ,. .. , \ , , , , \ ,
